HIRUDOID 25000UI * CREAM 40G
Therapeutic indications
Superficial thrombophlebitis and phlebitis, variceal inflammation states, hematomas.
Dosage and method of use
Cream: in small inflammatory processes, apply a 3-5 cm long stream of cream 1-2 times a day (about 0.5-1 g) or cover with a gauze tablet coated with Hirudoid 25000 IU cream. The cream can be lightly rubbed in the vicinity of the diseased area; never rub on the inflamed part. In more extensive processes, larger quantities of the drug are required: about 25 cm (about 4 to 6 g) of cream per day. Practice the treatment for 3-4 days, after this period halve the dose until the symptoms disappear; Gel: apply a 5-10 cm length of gel several times a day. In case of inflamed surfaces it is advisable not to rub on the diseased part but in the immediate vicinity. Hirudoid 25000 IU gel is particularly suitable for percutaneous therapy of large surfaces. Larger quantities of the drug are then required. Practice the treatment for 3-4 days; after this period, halve the dose until the symptoms disappear.
Contraindications
Hypersensitivity to the active substance, to a heparinoid or to any of the excipients listed in section 6.1.
Side effects
No undesirable effects known Reporting of suspected adverse reactions The reporting of suspected adverse reactions occurring after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit / risk ratio of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.
Special warnings
The use, especially if prolonged, of products for cutaneous use can give rise to sensitization phenomena, in which case the treatment must be interrupted. Hirudoid 25000 IU gel and cream contain an alcohol among the excipients and therefore should not be applied to open wounds or mucous membranes. Important information about some of the ingredients Hirudoid 25000 IU cream contains parahydroxybenzoates which can cause allergic reactions (possibly delayed). contains lanolin and cetylstearyl alcohol which can cause local skin reactions (eg contact dermatitis). Hirudoid 25000 IU gel This medicinal product contains 5 mg of propylene glycol per g of gel.
Pregnancy and breastfeeding
There are no special precautions or warnings for the product in case of pregnancy and lactation
Expiration and retention
This medicine does not require any special storage conditions.
Interactions with other drugs
There are no known interactions with other medicines
Overdose
No particular effects due to overdose are reported.
Active principles
100 g of cream contain: Active ingredient: glycosaminoglycanopolysulphate (PM 5700-13700) 0.3 g equal to 25000 IU Excipients with known effect: 7.515 g of lanolin, 0.160 g of methyl parahydroxybenzoate, 0.040 g of propyl parahydroxybenzoate and 3.105 g of cetostearyl alcohol. 100 g of gel contain: Active ingredient: glycosaminoglycanopolysulphate (PM 5700-13700) 0.3 g, equal to 25000 IU Excipients with known effect: 0.50 g of propylene glycol (E1520). For the full list of excipients, see section 6.1.
Excipients
Cream: glycerin, potassium hydroxide, stearic acid, lanolin, cetostearyl alcohol, myristic alcohol, thymol, methyl parahydroxybenzoate, propyl parahydroxybenzoate, isopropyl alcohol, purified water. Gel: isopropanol, polyacrylic acid, propylene glycol (E1520), sodium hydroxide, purified water.